Modulation of Soluble Receptor for Advanced Glycation End Products by Angiotensin-Converting Enzyme-1 Inhibition in Diabetic Nephropathy

Soluble Receptor ◽

Converting Enzyme ◽

Advanced Glycation ◽

Glycation End Products ◽

Renal accumulation and clearance of advanced glycation end-products in type 2 diabetic nephropathy: effect of angiotensin-converting enzyme and vasopeptidase inhibition

Diabetologia ◽

10.1007/s00125-005-1837-9 ◽

2005 ◽

Vol 48 (8) ◽

pp. 1645-1653 ◽

Cited By ~ 32

Author(s):

C. Wihler ◽

S. Schäfer ◽

K. Schmid ◽

E. K. Deemer ◽

G. Münch ◽

...

Keyword(s):

Diabetic Nephropathy ◽

Converting Enzyme ◽

Advanced Glycation ◽

Vasopeptidase Inhibition ◽

Glycation End Products ◽

End Products ◽

Type 2 Diabetic

Olmesartan Blocks Advanced Glycation End Products-Induced VCAM-1 Gene Expression in Mesangial Cells by Restoring Angiotensin-Converting Enzyme 2 Level

Hormone and Metabolic Research ◽

10.1055/s-0033-1361114 ◽

2013 ◽

Vol 46 (06) ◽

pp. 379-383

Author(s):

Y. Ishibashi ◽

T. Matsui ◽

S. Yamagishi

Keyword(s):

Gene Expression ◽

Mesangial Cells ◽

Converting Enzyme ◽

Advanced Glycation ◽

Angiotensin Converting Enzyme 2 ◽

Glycation End Products ◽

Effects of Angiotensin-Converting Enzyme Polymorphism on Soluble Receptor for Advanced Glycation End-Products in Maintenance Hemodialysis Patients

Korean Journal of Medicine ◽

10.3904/kjm.2013.85.5.495 ◽

2013 ◽

Vol 85 (5) ◽

pp. 495

Author(s):

Kang Won Lee ◽

Jeong Min Cha ◽

Yu Min Lee ◽

Seok Don Park ◽

Ju Hung Song ◽

...

Keyword(s):

Hemodialysis Patients ◽

Enzyme Polymorphism ◽

Maintenance Hemodialysis ◽

Soluble Receptor ◽

Converting Enzyme ◽

Advanced Glycation ◽

Glycation End Products ◽

End Products ◽

Maintenance Hemodialysis Patients

CILOSTAZOL ATTENUATES DIABETIC NEPHROPATHY IN RATS VIA ELEVATION OF PLASMA SOLUBLE RECEPTOR FOR ADVANCED GLYCATION END-PRODUCTS

Al-Azhar Journal of Pharmaceutical Sciences ◽

10.21608/ajps.2021.153569 ◽

2021 ◽

Vol 63 (1) ◽

pp. 207-223

Author(s):

Soad Kabil

Keyword(s):

Diabetic Nephropathy ◽

Soluble Receptor ◽

Advanced Glycation ◽

Glycation End Products ◽

Association of Soluble Receptor for Advanced Glycation End Products Levels with Hypertensive Albuminuria

Current Vascular Pharmacology ◽

10.2174/1570161111666131209143650 ◽

2015 ◽

Vol 13 (2) ◽

pp. 259-264

Author(s):

Huan Zheng ◽

Lingyan Yuan ◽

Nanzi Xie ◽

Huifeng Xu ◽

Xiaoyun Xie ◽

...

Keyword(s):

Soluble Receptor ◽

Advanced Glycation ◽

Glycation End Products ◽

Advanced Glycation End Products and Diabetic Nephropathy

American Journal of Therapeutics ◽

10.1097/01.mjt.0000178769.52610.69 ◽

2005 ◽

Vol 12 (6) ◽

pp. 562-572 ◽

Cited By ~ 70

Author(s):

Merlin C Thomas ◽

Josephine M Forbes ◽

Mark E Cooper

Keyword(s):

Diabetic Nephropathy ◽

Advanced Glycation ◽

Glycation End Products ◽

OS 13-04 SOLUBLE RECEPTOR FOR ADVANCED GLYCATION END-PRODUCTS AND INCREASED AORTIC STIFFNESS IN THE GENERAL POPULATION

Journal of Hypertension ◽

10.1097/01.hjh.0000500453.93751.ab ◽

2016 ◽

Vol 34 (Supplement 1) ◽

pp. e208-e209

Author(s):

Jan Filipovsky ◽

Jitka Seidlerova ◽

Otto Mayer ◽

Petra Karnosova

Keyword(s):

General Population ◽

Aortic Stiffness ◽

Soluble Receptor ◽

Advanced Glycation ◽

Glycation End Products ◽

Detection of feto-maternal infection/inflammation by the soluble receptor for advanced glycation end products (sRAGE): results of a pilot study

Journal of Perinatal Medicine ◽

10.1515/jpm.2008.080 ◽

2008 ◽

Vol 36 (5) ◽

Cited By ~ 19

Author(s):

Zdeněk Hájek ◽

Anna Germanová ◽

Michal Koucký ◽

Tomáš Zima ◽

Pavel Kopecký ◽

...

Keyword(s):

Pilot Study ◽

Soluble Receptor ◽

Maternal Infection ◽

Advanced Glycation ◽

Glycation End Products ◽

Advanced Glycation End Products (Ages) and Its Soluble Receptor in Smokers and Mild/Moderate COPD

Journal of Lung Diseases & Treatment ◽

10.4172/2472-1018.1000e106 ◽

2016 ◽

Vol 02 (03) ◽

Author(s):

Caram LMO ◽

Ferrari R ◽

Rasslan Z

Keyword(s):

Soluble Receptor ◽

Advanced Glycation ◽

Glycation End Products ◽

Serum levels of soluble receptor for advanced glycation end products are associated with restenosis after drug-eluting stent implantation for stable angina pectoris

Atherosclerosis ◽

10.1016/j.atherosclerosis.2015.04.1012 ◽

2015 ◽

Vol 241 (1) ◽

pp. e214

Author(s):

S. Byazrova ◽

S. Kozlov ◽

Z. Gabbasov ◽

V. Kukharchuk ◽

V. Masenko

Keyword(s):

Angina Pectoris ◽

Serum Levels ◽

Drug Eluting Stent ◽

Soluble Receptor ◽

Advanced Glycation ◽

Stable Angina Pectoris ◽

Glycation End Products ◽

End Products ◽

Drug Eluting